GSK logo

GSK plc (GSK) Net income

annual net income:

$3.77B-$2.83B(-42.85%)
December 31, 2024

Summary

  • As of today (August 18, 2025), GSK annual net profit is $3.77 billion, with the most recent change of -$2.83 billion (-42.85%) on December 31, 2024.
  • During the last 3 years, GSK annual net income has fallen by -$1.06 billion (-22.02%).
  • GSK annual net income is now -70.52% below its all-time high of $12.79 billion, reached on December 31, 2015.

Performance

GSK Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKincome statement metrics

quarterly net income:

$2.20B-$32.91M(-1.47%)
June 30, 2025

Summary

  • As of today (August 18, 2025), GSK quarterly net profit is $2.20 billion, with the most recent change of -$32.91 million (-1.47%) on June 30, 2025.
  • Over the past year, GSK quarterly net income has increased by +$553.30 million (+33.63%).
  • GSK quarterly net income is now -81.89% below its all-time high of $12.14 billion, reached on March 31, 2015.

Performance

GSK quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKincome statement metrics

TTM net income:

$5.16B+$553.30M(+12.02%)
June 30, 2025

Summary

  • As of today (August 18, 2025), GSK TTM net profit is $5.16 billion, with the most recent change of +$553.30 million (+12.02%) on June 30, 2025.
  • Over the past year, GSK TTM net income has dropped by -$294.26 million (-5.40%).
  • GSK TTM net income is now -66.92% below its all-time high of $15.59 billion, reached on March 31, 2015.

Performance

GSK TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

GSK Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-42.9%+33.6%-5.4%
3 y3 years-22.0%+135.0%-0.5%
5 y5 years-43.9%-27.4%-44.2%

GSK Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-42.9%at low-1.5%+2501.9%-35.6%+43.5%
5 y5-year-54.0%at low-27.4%+2501.9%-44.2%+43.5%
alltimeall time-70.5%+554.6%-81.9%+320.7%-66.9%+3426.3%

GSK Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
$2.20B(-1.5%)
$5.16B(+12.0%)
Mar 2025
-
$2.23B(+247.5%)
$4.60B(+23.0%)
Dec 2024
$3.77B(-42.9%)
$642.07M(+659.8%)
$3.74B(+4.1%)
Sep 2024
-
$84.50M(-94.9%)
$3.59B(-34.1%)
Jun 2024
-
$1.65B(+20.0%)
$5.45B(-9.0%)
Mar 2024
-
$1.37B(+177.6%)
$5.99B(-9.3%)
Dec 2023
$6.60B(+8.9%)
$493.76M(-74.6%)
$6.60B(-17.6%)
Sep 2023
-
$1.94B(-11.1%)
$8.01B(+14.7%)
Jun 2023
-
$2.18B(+10.2%)
$6.99B(+21.8%)
Mar 2023
-
$1.98B(+4.0%)
$5.74B(-6.4%)
Dec 2022
$6.06B(+25.4%)
$1.91B(+108.1%)
$6.13B(+28.0%)
Sep 2022
-
$915.80M(-2.1%)
$4.79B(-7.5%)
Jun 2022
-
$935.73M(-60.6%)
$5.18B(-14.0%)
Mar 2022
-
$2.37B(+319.6%)
$6.02B(+11.8%)
Dec 2021
$4.84B(-41.0%)
$566.05M(-56.6%)
$5.38B(-9.1%)
Sep 2021
-
$1.30B(-26.7%)
$5.93B(-8.4%)
Jun 2021
-
$1.78B(+2.3%)
$6.47B(-16.2%)
Mar 2021
-
$1.74B(+56.8%)
$7.72B(-5.0%)
Dec 2020
$8.19B(+21.9%)
$1.11B(-40.0%)
$8.13B(-9.4%)
Sep 2020
-
$1.85B(-39.0%)
$8.97B(-2.9%)
Jun 2020
-
$3.03B(+41.2%)
$9.24B(+22.2%)
Mar 2020
-
$2.15B(+9.9%)
$7.56B(+12.9%)
Dec 2019
$6.72B(+24.6%)
$1.95B(-7.7%)
$6.70B(+4.4%)
Sep 2019
-
$2.12B(+56.7%)
$6.42B(+2.3%)
Jun 2019
-
$1.35B(+5.2%)
$6.28B(+12.6%)
Mar 2019
-
$1.28B(-23.3%)
$5.57B(+4.2%)
Dec 2018
$5.39B(+93.1%)
$1.67B(-15.1%)
$5.34B(+67.5%)
Sep 2018
-
$1.97B(+205.1%)
$3.19B(+4.8%)
Jun 2018
-
$645.75M(-38.9%)
$3.05B(+33.0%)
Mar 2018
-
$1.06B(-319.3%)
$2.29B(-16.7%)
Dec 2017
$2.79B(+95.4%)
-$481.58M(-126.4%)
$2.75B(-24.1%)
Sep 2017
-
$1.82B(-1757.4%)
$3.62B(+22.4%)
Jun 2017
-
-$110.11M(-107.3%)
$2.96B(+24.8%)
Mar 2017
-
$1.52B(+287.0%)
$2.37B(+75.1%)
Dec 2016
$1.43B(-88.8%)
$391.60M(-66.3%)
$1.35B(+333.0%)
Sep 2016
-
$1.16B(-266.3%)
$312.54M(+113.7%)
Jun 2016
-
-$698.18M(-240.0%)
$146.23M(-85.7%)
Mar 2016
-
$498.60M(-176.8%)
$1.02B(-91.9%)
Dec 2015
$12.79B(+174.4%)
-$649.11M(-165.2%)
$12.67B(-15.2%)
Sep 2015
-
$994.92M(+459.9%)
$14.94B(+2.4%)
Jun 2015
-
$177.69M(-98.5%)
$14.58B(-6.5%)
Mar 2015
-
$12.14B(+648.3%)
$15.59B(+235.8%)
Dec 2014
$4.66B(-47.1%)
$1.62B(+154.4%)
$4.64B(-34.7%)
Sep 2014
-
$637.84M(-46.3%)
$7.11B(-11.5%)
Jun 2014
-
$1.19B(-0.6%)
$8.04B(-5.6%)
Mar 2014
-
$1.20B(-70.8%)
$8.52B(-4.5%)
Dec 2013
$8.81B(+18.9%)
$4.09B(+161.4%)
$8.92B(+44.9%)
Sep 2013
-
$1.57B(-5.9%)
$6.15B(-4.6%)
Jun 2013
-
$1.66B(+4.3%)
$6.45B(-5.8%)
Mar 2013
-
$1.60B(+20.2%)
$6.85B(-7.6%)
Dec 2012
$7.41B(-15.3%)
$1.33B(-28.7%)
$7.41B(-8.7%)
Sep 2012
-
$1.86B(-9.7%)
$8.11B(-5.4%)
Jun 2012
-
$2.06B(-4.4%)
$8.57B(+2.3%)
Mar 2012
-
$2.16B(+6.3%)
$8.38B(-4.3%)
Dec 2011
$8.75B(+205.9%)
$2.03B(-12.6%)
$8.76B(+52.8%)
Sep 2011
-
$2.32B(+24.2%)
$5.73B(+4.1%)
Jun 2011
-
$1.87B(-26.3%)
$5.51B(+68.9%)
Mar 2011
-
$2.54B(-354.7%)
$3.26B(+13.2%)
Dec 2010
$2.86B(-67.9%)
-$996.30M(-147.6%)
$2.88B(-56.4%)
Sep 2010
-
$2.09B(-656.6%)
$6.60B(-2.3%)
Jun 2010
-
-$376.29M(-117.4%)
$6.76B(-28.4%)
Mar 2010
-
$2.16B(-20.8%)
$9.44B(+5.4%)
Dec 2009
$8.90B(+2.6%)
$2.73B(+21.3%)
$8.96B(+15.0%)
Sep 2009
-
$2.25B(-2.6%)
$7.79B(+3.8%)
Jun 2009
-
$2.31B(+37.8%)
$7.51B(-3.6%)
Mar 2009
-
$1.68B(+7.7%)
$7.79B(-11.1%)
Dec 2008
$8.67B(-18.4%)
$1.56B(-20.9%)
$8.76B(-6.8%)
Sep 2008
-
$1.97B(-24.1%)
$9.41B(-7.4%)
Jun 2008
-
$2.59B(-2.2%)
$10.16B(-1.0%)
Mar 2008
-
$2.65B(+20.4%)
$10.26B(-3.3%)
Dec 2007
$10.63B(+5.0%)
$2.20B(-19.1%)
$10.61B(-1.0%)
Sep 2007
-
$2.72B(+1.1%)
$10.72B(+0.4%)
Jun 2007
-
$2.69B(-10.2%)
$10.67B(+2.4%)
Mar 2007
-
$3.00B(+29.9%)
$10.42B(+3.1%)
Dec 2006
$10.12B(+15.6%)
$2.31B(-13.7%)
$10.11B(+3.0%)
Sep 2006
-
$2.67B(+9.4%)
$9.81B(+4.7%)
Jun 2006
-
$2.44B(-8.8%)
$9.37B(+2.6%)
Mar 2006
-
$2.68B(+33.3%)
$9.13B(+4.2%)
Dec 2005
$8.75B
$2.01B(-10.1%)
$8.76B(+6.3%)
Sep 2005
-
$2.24B(+1.4%)
$8.25B(+4.3%)
DateAnnualQuarterlyTTM
Jun 2005
-
$2.21B(-4.6%)
$7.90B(+2.5%)
Mar 2005
-
$2.31B(+54.8%)
$7.71B(+4.9%)
Dec 2004
$7.37B(-1.8%)
$1.49B(-21.2%)
$7.35B(+1.4%)
Sep 2004
-
$1.89B(-5.8%)
$7.24B(-0.6%)
Jun 2004
-
$2.01B(+3.2%)
$7.29B(-2.4%)
Mar 2004
-
$1.95B(+40.3%)
$7.47B(-0.1%)
Dec 2003
$7.50B(+23.5%)
$1.39B(-28.3%)
$7.47B(-1.8%)
Sep 2003
-
$1.94B(-11.7%)
$7.61B(+9.6%)
Jun 2003
-
$2.19B(+12.3%)
$6.94B(+6.7%)
Mar 2003
-
$1.95B(+27.9%)
$6.51B(+7.5%)
Dec 2002
$6.07B(+32.2%)
$1.53B(+20.0%)
$6.05B(+1.1%)
Sep 2002
-
$1.27B(-27.7%)
$5.99B(+13.1%)
Jun 2002
-
$1.76B(+17.4%)
$5.29B(+5.3%)
Mar 2002
-
$1.50B(+2.5%)
$5.03B(+9.6%)
Dec 2001
$4.59B(-29.9%)
$1.46B(+152.2%)
$4.59B(-18.8%)
Sep 2001
-
$579.05M(-61.2%)
$5.65B(-8.5%)
Jun 2001
-
$1.49B(+41.4%)
$6.18B(+2.4%)
Mar 2001
-
$1.06B(-58.1%)
$6.03B(-3.5%)
Dec 2000
$6.55B(+34.2%)
$2.52B(+128.0%)
$6.25B(+39.6%)
Sep 2000
-
$1.11B(-17.9%)
$4.47B(+9.0%)
Jun 2000
-
$1.35B(+5.7%)
$4.10B(+16.4%)
Mar 2000
-
$1.27B(+70.1%)
$3.53B(+17.6%)
Dec 1999
$4.88B(+58.7%)
$748.61M(+1.9%)
$3.00B(-3.2%)
Sep 1999
-
$734.58M(-4.5%)
$3.10B(-3.1%)
Jun 1999
-
$769.18M(+3.1%)
$3.20B(+2.8%)
Mar 1999
-
$746.03M(-12.0%)
$3.11B(+2.2%)
Dec 1998
$3.08B(+0.6%)
$847.33M(+1.7%)
$3.04B(+7.6%)
Sep 1998
-
$833.17M(+21.9%)
$2.83B(+5.8%)
Jun 1998
-
$683.47M(+0.5%)
$2.67B(-5.4%)
Mar 1998
-
$680.26M(+7.8%)
$2.83B(-5.6%)
Dec 1997
$3.06B(-3.5%)
$631.02M(-7.1%)
$3.00B(-20.1%)
Sep 1997
-
$678.89M(-18.9%)
$3.75B(+15.3%)
Jun 1997
-
$836.67M(-1.4%)
$3.25B(+1.3%)
Mar 1997
-
$848.90M(-38.8%)
$3.21B(+1.2%)
Dec 1996
$3.17B(+98.1%)
$1.39B(+664.6%)
$3.17B(+77.5%)
Sep 1996
-
$181.27M(-77.2%)
$1.79B(-11.4%)
Jun 1996
-
$794.63M(-2.1%)
$2.02B(+21.9%)
Mar 1996
-
$811.76M(+97.4%)
$1.65B(-0.8%)
Dec 1995
$1.60B(-18.5%)
-
-
Sep 1995
-
$411.31M(-4.8%)
$1.67B(+0.3%)
Jun 1995
-
$431.87M(+6.5%)
$1.66B(+2.0%)
Mar 1995
-
$405.61M(-3.3%)
$1.63B(-3.9%)
Dec 1994
-
$419.37M(+3.3%)
$1.70B(-6.5%)
Sep 1994
-
$405.93M(+1.7%)
$1.81B(-6.5%)
Jun 1994
$1.96B(+0.5%)
$399.24M(-15.4%)
$1.94B(+0.4%)
Mar 1994
-
$471.74M(-12.3%)
$1.93B(-2.8%)
Dec 1993
-
$537.98M(+1.3%)
$1.99B(+4.0%)
Sep 1993
-
$531.29M(+35.4%)
$1.91B(+3.0%)
Jun 1993
$1.95B(+6.7%)
$392.26M(-25.6%)
$1.86B(+3.1%)
Mar 1993
-
$526.93M(+14.0%)
$1.80B(+1.5%)
Dec 1992
-
$462.18M(-2.9%)
$1.77B(-0.2%)
Sep 1992
-
$475.77M(+41.8%)
$1.78B(+0.2%)
Jun 1992
$1.83B(+7.0%)
$335.55M(-32.9%)
$1.77B(-7.9%)
Mar 1992
-
$499.82M(+7.2%)
$1.93B(+5.1%)
Dec 1991
-
$466.37M(-1.3%)
$1.83B(+5.3%)
Sep 1991
-
$472.50M(-3.0%)
$1.74B(+6.4%)
Jun 1991
$1.71B(+30.2%)
$487.06M(+19.9%)
$1.63B(+10.3%)
Mar 1991
-
$406.21M(+8.7%)
$1.48B(+3.0%)
Dec 1990
-
$373.54M(+1.5%)
$1.44B(+3.2%)
Sep 1990
-
$367.88M(+9.8%)
$1.40B(+3.0%)
Jun 1990
$1.31B(+11.2%)
$334.99M(-7.8%)
$1.35B(+0.2%)
Mar 1990
-
$363.21M(+10.4%)
$1.35B(+8.6%)
Dec 1989
-
$328.94M(+0.5%)
$1.25B(+3.7%)
Sep 1989
-
$327.45M(-1.5%)
$1.20B(+3.4%)
Jun 1989
$1.18B(+15.9%)
$332.29M(+29.5%)
$1.16B(+0.5%)
Mar 1989
-
$256.54M(-10.0%)
$1.16B(+2.6%)
Dec 1988
-
$284.94M(-1.1%)
$1.13B(+4.3%)
Sep 1988
-
$288.18M(-11.6%)
$1.08B(+3.5%)
Jun 1988
$1.02B(+31.0%)
$325.99M(+43.7%)
$1.04B(+10.2%)
Mar 1988
-
$226.85M(-4.8%)
$947.03M(+1.4%)
Dec 1987
-
$238.18M(-5.5%)
$933.59M(+7.6%)
Sep 1987
-
$252.17M(+9.7%)
$868.04M(+8.6%)
Jun 1987
$777.81M(+35.0%)
$229.83M(+7.7%)
$799.51M(+14.0%)
Mar 1987
-
$213.41M(+23.6%)
$701.22M(+9.6%)
Dec 1986
-
$172.64M(-6.0%)
$639.66M(+3.1%)
Sep 1986
-
$183.63M(+39.6%)
$620.56M(+5.5%)
Jun 1986
$576.08M
$131.55M(-13.4%)
$588.32M(+28.8%)
Mar 1986
-
$151.84M(-1.1%)
$456.77M(+49.8%)
Dec 1985
-
$153.54M(+1.4%)
$304.93M(+101.4%)
Sep 1985
-
$151.39M
$151.39M

FAQ

  • What is GSK plc annual net profit?
  • What is the all time high annual net income for GSK plc?
  • What is GSK plc annual net income year-on-year change?
  • What is GSK plc quarterly net profit?
  • What is the all time high quarterly net income for GSK plc?
  • What is GSK plc quarterly net income year-on-year change?
  • What is GSK plc TTM net profit?
  • What is the all time high TTM net income for GSK plc?
  • What is GSK plc TTM net income year-on-year change?

What is GSK plc annual net profit?

The current annual net income of GSK is $3.77B

What is the all time high annual net income for GSK plc?

GSK plc all-time high annual net profit is $12.79B

What is GSK plc annual net income year-on-year change?

Over the past year, GSK annual net profit has changed by -$2.83B (-42.85%)

What is GSK plc quarterly net profit?

The current quarterly net income of GSK is $2.20B

What is the all time high quarterly net income for GSK plc?

GSK plc all-time high quarterly net profit is $12.14B

What is GSK plc quarterly net income year-on-year change?

Over the past year, GSK quarterly net profit has changed by +$553.30M (+33.63%)

What is GSK plc TTM net profit?

The current TTM net income of GSK is $5.16B

What is the all time high TTM net income for GSK plc?

GSK plc all-time high TTM net profit is $15.59B

What is GSK plc TTM net income year-on-year change?

Over the past year, GSK TTM net profit has changed by -$294.26M (-5.40%)
On this page